ARYA Sciences Acquisition Corp IV (ARYD): Price and Financial Metrics
ARYD Price/Volume Stats
| Current price | $10.83 | 52-week high | $10.89 |
| Prev. close | $10.82 | 52-week low | $9.91 |
| Day low | $10.83 | Volume | 100 |
| Day high | $10.83 | Avg. volume | 79,902 |
| 50-day MA | $10.59 | Dividend yield | N/A |
| 200-day MA | $10.14 | Market Cap | 85.85M |
ARYD Stock Price Chart Interactive Chart >
ARYA Sciences Acquisition Corp IV (ARYD) Company Bio
ARYA Sciences Acquisition Corp IV focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.
Latest ARYD News From Around the Web
Below are the latest news stories about ARYA SCIENCES ACQUISITION CORP IV that investors may wish to consider to help them evaluate ARYD as an investment opportunity.
ARYA Sciences Acquisition Corp IV and Amicus Therapeutics, Inc. Mutually Agree to Terminate Business Combination Agreement With Respect to the Acquisition of Amicus’ Gene Therapy Business Due to Market ConditionsNEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) -- ARYA Sciences Acquisition Corp IV (NASDAQ: ARYD) (“ARYA IV”), a publicly traded special purpose acquisition company sponsored by Perceptive Advisors announced today that, due to existing market conditions, it has mutually agreed with Amicus Therapeutics, Inc. (Nasdaq: FOLD) (“Amicus”) to terminate their previously announced Business Combination Agreement (the “Business Combination Agreement”), effective immediately. “While this is not the outcome we ha |
ARYD Price Returns
| 1-mo | 0.65% |
| 3-mo | N/A |
| 6-mo | 4.84% |
| 1-year | 9.17% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 7.23% |
| 2022 | 1.87% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...